ATF5 and osteosarcoma: A study that screened for potential diagnostic and therapeutic markers for osteosarcoma revealed that ATF5 is among the up-regulated genes that are strongly associated with poor prognosis and recurrence, indicating that ATF5 can be a putative target for osteosarcoma treatment [79].